GlaxoSmithKline Consumer Healthcare LP is a leading global healthcare company that operates in the Health Supplement Stores sector. The company is headquartered in the United States of America and is committed to improving the health and wellbeing of people around the world. GlaxoSmithKline Consumer Healthcare LP is a subsidiary of GlaxoSmithKline plc, a British multinational pharmaceutical company.

The company's mission is to help people do more, feel better, and live longer. They achieve this by developing innovative products and solutions that address some of the world's most pressing health challenges. GlaxoSmithKline Consumer Healthcare LP has a diverse portfolio of products that includes over-the-counter medicines, nutritional supplements, and oral care products.

In recent years, GlaxoSmithKline Consumer Healthcare LP has made significant progress in decarbonisation and corporate energy. The company has set ambitious targets to reduce its greenhouse gas emissions and improve energy efficiency. They have also invested in renewable energy sources such as wind and solar power to reduce their reliance on fossil fuels.

One of the key initiatives that GlaxoSmithKline Consumer Healthcare LP has undertaken to achieve its decarbonisation goals is the implementation of a corporate power purchase agreement (PPA). A PPA is a long-term contract between a company and a renewable energy provider that guarantees the purchase of a certain amount of renewable energy at a fixed price. By entering into a PPA, GlaxoSmithKline Consumer Healthcare LP is able to secure a reliable and cost-effective source of renewable energy while reducing its carbon footprint.

GlaxoSmithKline Consumer Healthcare LP has also implemented a number of energy efficiency measures across its operations. These include the installation of energy-efficient lighting and HVAC systems, the use of energy-efficient equipment, and the implementation of energy management systems. These measures have helped the company to reduce its energy consumption and greenhouse gas emissions while also lowering its operating costs.

In addition to its efforts in decarbonisation and corporate energy, GlaxoSmithKline Consumer Healthcare LP is also committed to promoting renewable energy and sustainability more broadly. The company is a member of the RE100 initiative, which is a global collaborative platform that brings together businesses committed to 100% renewable electricity. GlaxoSmithKline Consumer Healthcare LP has committed to sourcing 100% of its electricity from renewable sources by 2030.

Overall, GlaxoSmithKline Consumer Healthcare LP is a leader in the Health Supplement Stores sector when it comes to decarbonisation, corporate energy, corporate PPA, and renewable energy. The company's commitment to sustainability is reflected in its ambitious targets and its investment in renewable energy sources. By taking a proactive approach to sustainability, GlaxoSmithKline Consumer Healthcare LP is not only reducing its environmental impact but also creating value for its stakeholders and contributing to a more sustainable future.